Lack of long-term durability of cultured keratinocyte burn-wound coverage: a case report.

PubWeight™: 1.16‹?› | Rank: Top 10%

🔗 View Article (PMID 1779008)

Published in J Burn Care Rehabil on March 09, 1992

Authors

M H Desai1, J M Mlakar, R L McCauley, K M Abdullah, R L Rutan, J P Waymack, M C Robson, D N Herndon

Author Affiliations

1: Shriners Burns Institute, Galveston, TX 77550.

Articles by these authors

Persistence of muscle catabolism after severe burn. Surgery (2000) 3.34

Determinants of skeletal muscle catabolism after severe burn. Ann Surg (2000) 2.56

Association of hyperglycemia with increased mortality after severe burn injury. J Trauma (2001) 2.55

Derived pulmonary capillary pressure changes after smoke inhalation in sheep. Crit Care Med (1991) 2.15

Definitions and guidelines for assessment of wounds and evaluation of healing. Arch Dermatol (1994) 2.01

Effects of a 12-wk resistance exercise program on skeletal muscle strength in children with burn injuries. J Appl Physiol (1985) (2001) 1.93

Mortality determinants in massive pediatric burns. An analysis of 103 children with > or = 80% TBSA burns (> or = 70% full-thickness). Ann Surg (1997) 1.91

Effect of severe burn injury on substrate cycling by glucose and fatty acids. N Engl J Med (1987) 1.90

An endogenous source for wound infections based on quantitative bacteriology of the biliary tract. Surgery (1970) 1.87

Testosterone administration in severe burns ameliorates muscle catabolism. Crit Care Med (2001) 1.78

A submaximal dose of insulin promotes net skeletal muscle protein synthesis in patients with severe burns. Ann Surg (1999) 1.76

Efficacy of a high-carbohydrate diet in catabolic illness. Crit Care Med (2001) 1.76

A comparison of conservative versus early excision. Therapies in severely burned patients. Ann Surg (1989) 1.67

Electrical injuries: a 30-year review. J Trauma (1999) 1.66

Anabolic effects of oxandrolone after severe burn. Ann Surg (2001) 1.65

Effects of recombinant human growth hormone on donor-site healing in severely burned children. Ann Surg (1990) 1.65

Effect of exogenous growth hormone on whole-body and isolated-limb protein kinetics in burned patients. Arch Surg (1991) 1.64

Stimulation of muscle protein synthesis by long-term insulin infusion in severely burned patients. Ann Surg (1995) 1.63

A review of nutrition support for transplant patients. Nutr Clin Pract (1993) 1.62

Surgical Infection Society intra-abdominal infection study. Prospective evaluation of management techniques and outcome. Arch Surg (1993) 1.59

Effect on mortality of inhalation injury. J Trauma (1986) 1.58

Growth delay in postburn pediatric patients. Arch Surg (1990) 1.56

Cleavage of the cell-surface O-sialoglycoproteins CD34, CD43, CD44, and CD45 by a novel glycoprotease from Pasteurella haemolytica. J Immunol (1992) 1.54

Bacterial quantification of open wounds. Mil Med (1969) 1.53

Quantitative bacterial analysis of comparative wound irrigations. Ann Surg (1975) 1.52

The effect of human amniotic membranes on the bacteria population of infected rat burns. Ann Surg (1973) 1.51

Histomorphometric and biochemical characterization of bone following acute severe burns in children. Bone (1995) 1.51

Development and analysis of a small animal model simulating the human postburn hypermetabolic response. J Surg Res (1978) 1.51

An analysis of 1,423 facial fractures in 788 patients at an urban trauma center. J Trauma (1989) 1.49

Nutritional intervention high in vitamins, protein, amino acids, and omega3 fatty acids improves protein metabolism during the hypermetabolic state after thermal injury. Arch Surg (2001) 1.49

Transplanted acellular allograft dermal matrix. Potential as a template for the reconstruction of viable dermis. Transplantation (1995) 1.46

Pressure sore volume measurement. A technique to document and record wound healing. J Am Geriatr Soc (1988) 1.45

Evolution of quantitative bacteriology in wound management. Am J Surg (1975) 1.45

Inventory of potential reconstructive needs in the patient with burns. J Burn Care Rehabil (1990) 1.45

CD4- CD8- TCR alpha/beta+ suppressor T cells demonstrated in mice 1 day after thermal injury. J Trauma (1997) 1.42

The effect of denervation on soft-tissue infection pathophysiology. Plast Reconstr Surg (1992) 1.42

Bacterial control in the burn wound. Clin Plast Surg (1979) 1.41

Owner's perception of carboplatin in conjunction with other palliative treatments for cancer therapy. J Small Anim Pract (2010) 1.41

Gene expression in intestinal epithelial cells, IEC-6, is altered by burn injury-induced circulating factors. Shock (2001) 1.40

Biobrane versus 1% silver sulfadiazine in second-degree pediatric burns. Plast Reconstr Surg (2000) 1.40

The 1995 Clinical Research Award. Younger pediatric patients with burns are at risk for continuing postdischarge weight loss. J Burn Care Rehabil (1996) 1.39

Long-term outcomes of burned children after in-hospital cardiac arrest. Crit Care Med (2000) 1.39

Attenuation of posttraumatic muscle catabolism and osteopenia by long-term growth hormone therapy. Ann Surg (2001) 1.38

Acute effects of tobacco smoking on blood flow in the cutaneous micro-circulation. Br J Plast Surg (1984) 1.38

Reconstruction of the burned palm: full-thickness versus split-thickness skin grafts--long-term follow-up. Plast Reconstr Surg (1988) 1.37

Long-term reduction in bone mass after severe burn injury in children. J Pediatr (1995) 1.37

Recombinant human growth hormone accelerates wound healing in children with large cutaneous burns. Ann Surg (1994) 1.34

Comparison of serial debridement and autografting and early massive excision with cadaver skin overlay in the treatment of large burns in children. J Trauma (1986) 1.33

Reduction in mortality in pediatric patients with inhalation injury with aerosolized heparin/N-acetylcystine [correction of acetylcystine] therapy. J Burn Care Rehabil (1998) 1.31

Effects of insulin on wound healing. J Trauma (1998) 1.28

Definitions and guidelines for assessment of wounds and evaluation of healing. Wound Repair Regen (1994) 1.28

The isolated burned palm in children: epidemiology and long-term sequelae. Plast Reconstr Surg (2000) 1.26

Inhalation injury in burned patients: effects and treatment. Burns Incl Therm Inj (1988) 1.25

Detection of platelet-derived growth factor (PDGF)-AA in actively healing human wounds treated with recombinant PDGF-BB and absence of PDGF in chronic nonhealing wounds. J Clin Invest (1995) 1.25

Ultrastructural aspects of cooled thermal injury. J Trauma (1981) 1.25

Current treatment of severely burned patients. Ann Surg (1996) 1.25

Transforming growth factor beta(2) lowers the incidence of incisional hernias. J Surg Res (2001) 1.23

Bone disease in burn patients. J Bone Miner Res (1993) 1.23

Dysregulation of calcium homeostasis after severe burn injury in children: possible role of magnesium depletion. J Pediatr (1997) 1.22

Regulation of lipolysis in severely burned children. Ann Surg (1987) 1.22

Inhibition of muscle glutamine formation in hypercatabolic patients. Clin Sci (Lond) (2000) 1.21

Biobrane improves wound healing in burned children without increased risk of infection. Shock (2000) 1.20

Early burn wound excision significantly reduces blood loss. Ann Surg (1990) 1.20

Short-term oxandrolone administration stimulates net muscle protein synthesis in young men. J Clin Endocrinol Metab (1999) 1.20

Dynamics of the protein metabolic response to burn injury. Metabolism (1988) 1.19

Does inhalation injury limit exercise endurance in children convalescing from thermal injury? J Burn Care Rehabil (1993) 1.18

Frostbite injuries: a rational approach based on the pathophysiology. J Trauma (1983) 1.18

Hypochlorous acid as a potential wound care agent: part I. Stabilized hypochlorous acid: a component of the inorganic armamentarium of innate immunity. J Burns Wounds (2007) 1.18

Fatty infiltration of the liver in severely burned pediatric patients: autopsy findings and clinical implications. J Trauma (2001) 1.17

Determination of endogenous cytokines in chronic wounds. Ann Surg (1994) 1.17

Treatment of extensive toxic epidermal necrolysis in children. Pediatrics (2001) 1.17

Prolonged use of propranolol safely decreases cardiac work in burned children. J Burn Care Rehabil (1997) 1.17

Anabolic effects of insulin-like growth factor in combination with insulin-like growth factor binding protein-3 in severely burned adults. J Trauma (1999) 1.16

Rapid bacterial screening in the treatment of civilian wounds. J Surg Res (1973) 1.16

Growth hormone treatment in pediatric burns: a safe therapeutic approach. Ann Surg (1998) 1.15

Chemical parameters, antimicrobial activities, and tissue toxicity of 0.1 and 0.5% sodium hypochlorite solutions. Antimicrob Agents Chemother (1985) 1.15

Trauma, shock, and gut translocation. New Horiz (1996) 1.15

The effect of prolonged euglycemic hyperinsulinemia on lean body mass after severe burn. Surgery (2002) 1.14

The efficacy of systemic antibiotics in the treatment of granulating wounds. J Surg Res (1974) 1.13

Differentiation between septic and postburn insulin resistance. Metabolism (1989) 1.13

The role of autopsy in death resulting from trauma. J Trauma (1990) 1.13

Effect of ibuprofen on the inflammatory response to surgical wounds. J Trauma (1993) 1.13

The effects of hyperglycemia on skin graft survival in the burn patient. Ann Plast Surg (2000) 1.13

Recombinant human growth hormone treatment in pediatric burn patients and its role during the hepatic acute phase response. Crit Care Med (2000) 1.13

Improved myocardial oxygen utilization following propranolol infusion in adolescents with postburn hypermetabolism. J Pediatr Surg (1989) 1.13

Mandibular fractures in an urban trauma center. J Trauma (1986) 1.11

Beta-blockade lowers peripheral lipolysis in burn patients receiving growth hormone. Rate of hepatic very low density lipoprotein triglyceride secretion remains unchanged. Ann Surg (1996) 1.11

Biosynthetic skin substitute versus frozen human cadaver allograft for temporary coverage of excised burn wounds. J Trauma (1987) 1.11

Enhancement of incisional wound healing and neovascularization in normal rats by thrombin and synthetic thrombin receptor-activating peptides. J Clin Invest (1992) 1.11

Quantitative bacteriology and delayed wound closure. Surg Forum (1968) 1.11